X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.biospace.com/article/genentech-partners-with-chinese-biopharma-for-prostate-cancer-androgen-receptor-degrader/
https://www.prnewswire.com/news-releases/jemincare-announces-exclusive-license-agreement-with-genentech-to-develop-and-commercialize-novel-oral-androgen-receptor-degrader-301608317.html
https://www.biospectrumasia.com/news/25/20241/orion-partners-with-jemincare-for-novel-non-opioid-drug-candidate-for-pain-treatment.html
https://www.prnewswire.com/news-releases/le-groupe-jemincare-a-termine-l-essai-clinique-de-phase-i-de-son-anticorps-neutralisant-anti-sars-cov-2-le-jmb2002--846114416.html
https://www.prnewswire.com/news-releases/jemincare-group-has-completed-the-phase-i-clinical-trial-of-its-anti-sars-cov-2-neutralizing-antibody-jmb2002-301375889.html
https://www.biospectrumasia.com/news/25/18909/wockhardt-bio-partners-with-china-based-jemincare-for-pneumonia-drug.html
https://www.prnewswire.com/news-releases/us-fda-approved-jemincare-to-initiate-clinical-trial-of-neutralizing-antibody-jmb2002-301261264.html
https://en.prnasia.com/releases/global/us-fda-approved-jemincare-to-initiate-clinical-trial-of-neutralizing-antibody-jmb2002-313826.shtml
Market Place
Share 
